TGFB1 and gastric cancer: It was found that the inhibitory effect of miR-361-3p on GC growth, migration, and glycolysis could be reversed by the overexpression of TGF-β1, suggesting that miR-361-3p inhibited the growth, metastasis, and glycolysis of GC cells by targeting TGF-β1 [70].